| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |